CLINICAL_TRIALS
trial_result
· 2020-03-19
Clinical Trial Update: European Sickle Cell Disease Cohort - Hydroxyurea
Summary
A completed European cohort study evaluating hydroxyurea for sickle cell disease with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Theravia | Conditions: Sickle Cell Disease | Status: COMPLETED | Results posted: 2020-03-19